#USA #New York #Class Action #The Gross Law Firm #Baxter International

Important Notice to Baxter International Shareholders

Shareholders of Baxter International, Inc. (NYSE: BAX) who have suffered financial losses during the class action period are advised to reach out to The Gross Law Firm for assistance concerning a pending class action lawsuit. This notice represents a significant opportunity for stockholders affected by discrepancies in the company's disclosures.

Class Action Details

The Gross Law Firm has announced that shareholders who bought shares of Baxter from February 23, 2022, to July 30, 2025, may have grounds for a legal claim. Alarming allegations have emerged regarding Baxter's newly launched product, the Novum LVP, which reportedly experienced systemic issues that compromised patient safety. These issues included severe malfunctions like underinfusion, overinfusion, and total failure to deliver fluids, which could expose patients to critical risks.

During the stated period, it is alleged that Baxter materially misrepresented the safety and effectiveness of Novum LVPs and failed to properly disclose the product's defects despite receiving notifications of dangers, injuries, and fatalities tied to the malfunctioning devices.

What Shareholders Need to Know

Shareholders with concerns regarding their investments in Baxter International are strongly encouraged to consider registering for this class action. Notably, being appointed as a lead plaintiff is voluntary and not a requirement for participation in potential recoveries.

Investors should be aware of the following key points related to this class action:

• - Registration Deadline: Shareholders must register by December 15, 2025. This is imperative to secure a position in the ongoing proceedings.
• - Monitoring and Updates: Once registered, participants will have access to portfolio monitoring software that will keep them informed on the progression of the case.
• - No Financial Obligation: Participating in this class action lawsuit will cost shareholders nothing, and they remain obligated only to provide accurate information related to their share purchase.

Next Steps for Interested Shareholders

For those willing to pursue this matter, registering is a simple process. Interested shareholders can click the link to the registration form here, where they can submit their details before the deadline.

This lawsuit highlights the commitment of The Gross Law Firm to uphold the rights of investors against fraudulent practices and misleading corporate communications. The firm specializes in class action cases and seeks to protect stakeholders' interests by holding companies accountable for their actions.

If you have been affected by Baxter International’s alleged misleading statements about its product safety and efficacy, reaching out to The Gross Law Firm may provide a critical avenue for recovery. Their dedicated team is ready to assist clients in navigating the legal complexities involved in class actions.

For more information, or if you wish to ask questions, you can contact The Gross Law Firm directly at:

• - Phone: (646) 453-8903
• - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
• - Email: [email protected]

As the class action progresses, it’s crucial for shareholders to stay engaged and proactive in protecting their investments.